Alcidion Healthcare Technology (ASX:ACL)

$16.2m raised via an institutional placement to accelerate Alcidion’s growth strategy.

Henslow acted as Alcidion’s Lead manager to raise money via an institutional placement. Prior to that, Henslow also facilitated the on-market transfer of approximately $4.0m from Blue Sky Private Equity to a consortium of institutional investors.

Unlocking new innovation and insights in the healthcare industry.

Alcidion is transforming healthcare with smart, intuitive technology solutions that provide real-time clinical decision support. It integrates with EMR providers and assists doctors and nurses, covering functions such as; streamlining patient journeys, smart analytics to help with clinical decisions, improving patient safety, improving productivity amongst clinical staff through messaging applications, and data capture and interpretation.

The Highlights

  • $16.2m

    raised via an institutional placement

  • $4.0m

    on-market transfer to a consortium of institutional investors


    ASX Listed Company

Funds used to boost growth strategy through investment in sales, marketing and clinical support resources

We continue to support the company with corporate broking and advisory services and look forward to working closely with Alcidion as they strive towards making healthcare safer and more efficient for all.


November 2018

Block Trade $4.0m

November 2019

Placement $16.2m

“Alcidion is well-placed to scale up and pursue a significant global market opportunity. The adoption of technology in healthcare is accelerating, driven by access to digital patient data, increasing demands on healthcare and a shifting regulatory environment.”

Kate Quirke, Managing Director of Alcidion